---
title: "Prestige Consumer Healthcare Secures $1.045 Billion Term Loan, Expands ABL to $225 Million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289901664.md"
description: "Prestige Consumer Healthcare secured a $1.045 billion term loan to fund the Breathe Right acquisition and has an option for additional draws for LaCorium Health. Simultaneously, it amended its Asset-Based Lending agreement, increasing commitments to $225 million and extending the facility by five years. Citibank acts as administrative agent for both facilities."
datetime: "2026-06-16T10:23:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289901664.md)
  - [en](https://longbridge.com/en/news/289901664.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289901664.md)
generator: "portal-rs"
---

# Prestige Consumer Healthcare Secures $1.045 Billion Term Loan, Expands ABL to $225 Million

Prestige Consumer Healthcare closed two financing actions to support its growth plans. The company secured a $1.045 billion secured term loan to fund the acquisition of the Breathe Right business and related costs, with an option for an uncommitted second draw of up to $95 million for the planned LaCorium Health acquisition. Separately, Prestige amended its ABL Credit Agreement, lifting commitments to $225 million and extending the facility for five years, with availability-based access for LaCorium funding. Citibank serves as administrative agent on both facilities alongside participating lenders.

**Agreement 1: Prestige Consumer Healthcare Secures $1.045 Billion Term Loan to Fund Breathe Right Deal**

-   **Agreement type**: $1.045 billion secured term loan credit agreement with uncommitted incremental capacity
-   **Counterparty**: Citibank and other lenders
-   **Signed / Effective**: Jun 12 2026 / same
-   **Duration / Termination**: N/A
-   **Reason**: Finance Breathe Right acquisition and enhance liquidity for M&A

**Agreement 2: Prestige Consumer Healthcare Expands ABL Revolver to $225 Million, Extends Term to 5 Years**

-   **Agreement type**: Amendment to asset-based revolving credit facility
-   **Counterparty**: Citibank and other lenders
-   **Signed / Effective**: Jun 12 2026 / same
-   **Duration / Termination**: 5 years
-   **Reason**: Increase revolver capacity and extend maturity for flexibility

Original SEC Filing: Prestige Consumer Healthcare Inc. \[ PBH \] - 8-K - Jun. 16, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [PBH.US](https://longbridge.com/en/quote/PBH.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [ByteDance Secures $29.6 Billion Loan as It Weighs $70 Billion AI Spending](https://longbridge.com/en/news/297887523.md)
- [10:27 ETAgilyx ASA: ADRs begin trading today on the USA's OTCQX market](https://longbridge.com/en/news/297801230.md)
- [Growexa Launches Lender-Ready Business Plan Platform to Bridge Small Business Lending Gap](https://longbridge.com/en/news/297990726.md)
- [ZYUS Life Sciences Corporation Announces Completion of Secured Loan Financing](https://longbridge.com/en/news/297568176.md)
- [18:01 ETNEXA Lending Launches NEXA Unlimited, Giving Loan Officers Access to 100% of All Loans](https://longbridge.com/en/news/297703169.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**